Cargando…

Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines

Pancreatic cancer is one of the most fatal cancers and is associated with limited diagnostic and therapeutic modalities. Currently, gemcitabine is the only effective drug and represents the preferred first-line treatment for chemotherapy. However, a high level of intrinsic or acquired resistance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yikwon, Han, Dohyun, Min, Hophil, Jin, Jonghwa, Yi, Eugene C., Kim, Youngsoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275706/ https://www.ncbi.nlm.nih.gov/pubmed/25518923 http://dx.doi.org/10.14348/molcells.2014.0207

Ejemplares similares

Label-Free Quantitative Proteomics and N-terminal Analysis of Human Metastatic Lung Cancer Cells
por: Min, Hophil, et al.
Publicado: (2014)

Characterization of the membrane proteome and N-glycoproteome in BV-2 mouse microglia by liquid chromatography-tandem mass spectrometry
por: Han, Dohyun, et al.
Publicado: (2014)

Interactome analysis of AMP-activated protein kinase (AMPK)-α1 and -β1 in INS-1 pancreatic beta-cells by affinity purification-mass spectrometry
por: Moon, Sungyoon, et al.
Publicado: (2014)

Differential Proteome Profiling Using iTRAQ in Microalbuminuric and Normoalbuminuric Type 2 Diabetic Patients
por: Jin, Jonghwa, et al.
Publicado: (2012)

Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics
por: Jin, Jonghwa, et al.
Publicado: (2016)

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells
por: Chiu, Ching-Feng, et al.
Publicado: (2021)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma
por: Kuo, Kung-Kai, et al.
Publicado: (2016)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms
por: Do, Misol, et al.
Publicado: (2018)

Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
por: Vellan, Christina Jane, et al.
Publicado: (2022)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma
por: Choi, Munseok, et al.
Publicado: (2021)

Proteomic profiling of postmortem prefrontal cortex tissue of suicide completers
por: Kim, Min Ji, et al.
Publicado: (2022)

Proteome-Wide Alterations of Asymmetric Arginine Dimethylation Associated With Pancreatic Ductal Adenocarcinoma Pathogenesis
por: Wei, Meijin, et al.
Publicado: (2020)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Untargeted Metabolomics Analysis Reveals Toxicity Based on the Sex and Sexual Maturity of Single Low-Dose DEHP Exposure
por: Lee, Hyeon-Jeong, et al.
Publicado: (2023)

Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma
por: Song, Yang, et al.
Publicado: (2018)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
por: Thakur, Gitika, et al.
Publicado: (2021)

Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling
por: Werner, Janina, et al.
Publicado: (2023)

Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus
por: Kim, Yeon Jin, et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Circular RNA expression in pancreatic ductal adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2019)

Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis
por: Yanagisawa, Kiyoshi, et al.
Publicado: (2012)

Marker Identification of the Grade of Dysplasia of Intraductal Papillary Mucinous Neoplasm in Pancreatic Cyst Fluid by Quantitative Proteomic Profiling
por: Do, Misol, et al.
Publicado: (2020)

An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma
por: de Oliveira, Grasieli, et al.
Publicado: (2020)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

Single-cell profiling of microenvironment components by spatial localization in pancreatic ductal adenocarcinoma
por: Han, Song, et al.
Publicado: (2022)

The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
por: Evan, Theodore, et al.
Publicado: (2022)

Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma
por: Qu, Shibin, et al.
Publicado: (2015)

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Mahajan, Ujjwal Mukund, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8cl9b9b9o3cscfliq8jhlrjo3